Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Leflunomide [75706-12-6]
Cat# T1159-500mg
Size : 500mg
Brand : TargetMol
Contact local distributor :
Phone : +1 850 650 7790
Leflunomide
Catalog No. T1159 CAS 75706-12-6
Synonyms: SU101, RS-34821, HWA486
Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis.
All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Leflunomide, CAS 75706-12-6
| Description | Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. |
| Kinase Assay | DHODase activity is measured by the DCIP colorimetric assay. This is a coupled assay in which oxidation of DHO and subsequent reduction of ubiquinone are stoichiometrically equivalent to the reduction of DCIP. Reduction of DCIP is accompanied by a loss of absorbance at 610 nm (ε=21500 M/cm). The assay is performed in a 96-well microtiter plate at ambient temperature (ca. 25°C). Stock solutions of 10 mM leflunomide and A771726 are prepared in dimethyl sulfoxide (DMSO) and these are diluted with reaction buffer (100 mM Tris and 0.1 % Triton X-100, pH 8.0) to prepare working stocks of the inhibitors at varying concentrations. For each reaction, the well contained 10 nM DHODase, 68 μM DCIP, 0.16 mg/mL gelatin, the stated concentration of ubiquinone, 10 μL of an inhibitor working stock to give the stated final concentration, and reaction buffer. After a 5-min equilibration period, the reaction is initiated by addition of DHO to the stated final concentrations. The total volume of reaction mixture for each assay is 150 μL, and the final DMSO concentration is ≤ 0.01% (v/v). The reaction progress is followed by recording the loss of absorbance at 610 nm over a 10-min period (during which the velocity remained linear). Velocities are reported as the change in absorbance at 610 nm per minute, and each reported value is the average of three replicates. In experiments where the DHO or ubiquinone concentration is varied, the other substrate is held constant at 200 μM. To determine the inhibitor potency of leflunomide and A771726, the effects of varying concentrations of the two compounds on the initial velocity of the DHODase reaction is measured over a concentration range of 0.01?1.0 μM. In these experiments the DHO and ubiquinone concentrations are held constant at 200 and 100 μM, respectively. |
| Synonyms | SU101, RS-34821, HWA486 |
| Molecular Weight | 270.21 |
| Formula | C12H9F3N2O2 |
| CAS No. | 75706-12-6 |
Storage
Solubility Information
DMSO: 27 mg/mL (100 mM)
Ethanol: 27 mg/mL (100 mM)
References and Literature
1. Davis JP, et al. Biochemistry, 1996, 35(4), 1270-1273. 2. Xu X, et al. J Biol Chem. 1995, 270(21), 12398-12403. 3. Fox RI, et al. Clin Immunol, 1999, 93(3), 198-208. 4. Ferrini MG, et al. Urology. 2006 Aug;68(2):429-35.